March 17, 2016 / 8:46 PM / 4 years ago

BRIEF-Cymabay therapeutics announces results from mid-phase clinical study of MBX-8025

March 17 (Reuters) - - :

* Cymabay Therapeutics Inc announces positive results from its pilot phase 2 clinical study of MBX-8025 in patients with homozygous familial hypercholesterolemia

* Cymabay Therapeutics Inc announces plans to evaluate feasibility of conducting a pilot study of MBX-8025 in combination with a PCSK9 inhibitor Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below